VTRS

Viatris Inc Ord Shs

15.78

-0.04-0.22%

Opening09:43 06/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE15.70/15.56

TODAY RANGE15.64-15.99

VOL7.50M

MARKET CAP18.52B

52 WEEK RANGE8.08-17.40

AVG VOL (3M)10.88M

% TURNOVER0.64%

TURNOVER--

P/E (TTM)-61.4137

% RANGE2.25%

EPS(TTM)-0.2589

P/E(FORWARD)86.09

P/B1.263

BVPS12.59

DIVIDEND0.4800

P/S1.280

BETA--

DIV YIELD3.02%

FREE FLOAT MKT CAP18.46B

SHARES OUTSTANDING1.16B

NEXT EARNINGS08/05-08/10

FREE FLOAT1.16B

LOT SIZE1

EX-DATE05/22/2026

News

Press Releases

Financial Reports

Profile

TipRanks·12h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viatris (VTRS), Medtronic (MDT) and Vertex Pharmaceuticals (VRTX)
TipRanks·12h ago
Piper Sandler Sticks to Their Hold Rating for Viatris (VTRS)
PUBT·2d ago
Salesforce says Viatris selects Agentforce Life Sciences as global customer engagement platform
Seeking Alpha·3d ago
These 10 large-cap healthcare giants rank among the market's most attractively valued stocks
Simply Wall St·4d ago
Does FDA Review of Fast-Acting Meloxicam Shift Viatris’ (VTRS) Non-Opioid Pain Strategy?
TipRanks·6d ago
Piper Sandler Remains a Hold on Viatris (VTRS)
Seeking Alpha·05/28 17:36
Consumers could pay less for drugs with Mark Cuban pharmacy than own insurance
Seeking Alpha·05/28 08:09
90 Top Ten-Year Dog Collection Yields 22 Ideal Buys From 41 'Safer' Sorts In May
Simply Wall St·05/21 22:30
What Viatris (VTRS)'s Fast-Acting Pain Drug Filing and Profit Uptick Means For Shareholders
Reuters·05/19 10:32
VIATRIS INC. <VTRS.O>: BARCLAYS RAISES TARGET PRICE TO $22 FROM $17
Dow Jones·05/19 10:13
Viatris Is Maintained at Overweight by Barclays
Dow Jones·05/19 10:13
Viatris Price Target Raised to $22.00/Share From $17.00 by Barclays
TipRanks·05/19 09:20
Viatris price target raised to $22 from $17 at Barclays
TipRanks·05/19 08:37
Barclays Remains a Buy on Viatris (VTRS)
Reuters·05/19 07:56
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Same Industry

Name/Symbol

Change%

Price

Viatris Inc Ord Shs

VTRS

-0.22%

15.78

McKesson

MCK

-1.92%

742.44

Biogen Inc

BIIB

-2.98%

186.51

Amgen Inc

AMGN

+2.18%

345.60

SHPG

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+0.26%

0.1153

Lilly Eli & Co

LLY

-1.67%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

+1.42%

2.140

Johnson & Johnson

JNJ

-2.37%

225.33

Abbvie Inc

ABBV

-2.20%

212.93

ZTS

Gilead Sciences Inc

GILD

-1.31%

134.43

NVO

Bristol-Myers Squibb Co

BMY

+3.51%

56.64

ALXN

Pfizer

PFE

+1.48%

25.72

SNY

GCVRZ

Novartis

NVS

-0.81%

150.17

Dr Reddys Labs

RDY

-1.55%

13.06

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.